Daniel Loeb acquired 385 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $31.6 Million. That's 0.44% of their equity portfolio (25th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2007. Since then Daniel Loeb bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $34.1 Million, resulting in a loss of 7.2%.